David Dobkin - Net Worth and Insider Trading

David Dobkin Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, David Dobkin owns 5 companies in total, including Petra Acquisition Inc (PAICU) , LifeSci Acquisition Corp (LSACU) , and Revelation Biosciences Inc (REVB) among others .

Click here to see the complete history of David Dobkin’s form 4 insider trades.

Insider Ownership Summary of David Dobkin

Ticker	Comapny	Transaction Date	Type of Owner
PAICU	Petra Acquisition Inc	2020-10-07	director
LSACU	LifeSci Acquisition Corp	2020-03-05	director & Chief Financial Officer
REVB	Revelation Biosciences Inc	2020-10-07	director
		2020-11-20	director & Chief Financial Officer
		2020-03-05	director & Chief Financial Officer

David Dobkin Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

David Dobkin Ownership Network

Ownership Network List of David Dobkin

No Data

Ownership Network Relation of David Dobkin

David Dobkin Owned Company Details

What does Petra Acquisition Inc do?

Who are the key executives at Petra Acquisition Inc?

David Dobkin is the director of Petra Acquisition Inc. Other key executives at Petra Acquisition Inc include 10 percent owner Glazer Capital, Llc , 10 percent owner Paul J Glazer , and director & 10 percent owner & Chief Executive Officer Andreas Typaldos .

Petra Acquisition Inc (PAICU) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Petra Acquisition Inc (PAICU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Petra Acquisition Inc (PAICU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Petra Acquisition Inc (PAICU)'s detailed insider trading history can be found in Insider Trading Tracker table.

Petra Acquisition Inc Insider Transactions

No Available Data

What does LifeSci Acquisition Corp do?

Who are the key executives at LifeSci Acquisition Corp?

David Dobkin is the director & Chief Financial Officer of LifeSci Acquisition Corp. Other key executives at LifeSci Acquisition Corp include 10 percent owner Rubric Capital Management Lp , 10 percent owner David Efraim Rosen , and Chief Technology Officer Xiaoming Zhang .

LifeSci Acquisition Corp (LSACU) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of LifeSci Acquisition Corp (LSACU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of LifeSci Acquisition Corp (LSACU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

LifeSci Acquisition Corp (LSACU)'s detailed insider trading history can be found in Insider Trading Tracker table.

LifeSci Acquisition Corp Insider Transactions

No Available Data

What does Revelation Biosciences Inc do?

Who are the key executives at Revelation Biosciences Inc?

David Dobkin is the director of Revelation Biosciences Inc. Other key executives at Revelation Biosciences Inc include director & 10 percent owner George F Tidmarsh , other: Former 10% owner S.a. Axa , and other: Former 10% owner Axa Investment Managers Uk Ltd .

Revelation Biosciences Inc (REVB) Insider Trades Summary

Over the past 18 months, David Dobkin made no insider transaction in Revelation Biosciences Inc (REVB). Other recent insider transactions involving Revelation Biosciences Inc (REVB) include a net sale of 16,002 shares made by George F Tidmarsh ,

In summary, during the past 3 months, insiders sold 0 shares of Revelation Biosciences Inc (REVB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 2,250 shares of Revelation Biosciences Inc (REVB) were sold and 1,717 shares were bought by its insiders, resulting in a net sale of 533 shares.

Revelation Biosciences Inc (REVB)'s detailed insider trading history can be found in Insider Trading Tracker table.

Revelation Biosciences Inc Insider Transactions

No Available Data

What does Science 37 Holdings Inc do?

Who are the key executives at Science 37 Holdings Inc?

David Dobkin is the director & Chief Financial Officer of Science 37 Holdings Inc. Other key executives at Science 37 Holdings Inc include Chief Technology Officer Troy Bryenton , Chief Legal Officer Christine A Pellizzari , and Chief Commercial Officer Michael Shipton .

Science 37 Holdings Inc (SNCE) Insider Trades Summary

Over the past 18 months, David Dobkin made no insider transaction in Science 37 Holdings Inc (SNCE). Other recent insider transactions involving Science 37 Holdings Inc (SNCE) include a net purchase of 5,000 shares made by Christine A Pellizzari ,

In summary, during the past 3 months, insiders sold 0 shares of Science 37 Holdings Inc (SNCE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Science 37 Holdings Inc (SNCE) were sold and 250 shares were bought by its insiders, resulting in a net purchase of 250 shares.

Science 37 Holdings Inc (SNCE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Science 37 Holdings Inc Insider Transactions

No Available Data

What does Vincerx Pharma Inc do?

Who are the key executives at Vincerx Pharma Inc?

David Dobkin is the director & Chief Financial Officer of Vincerx Pharma Inc. Other key executives at Vincerx Pharma Inc include Chief Financial Officer Alexander A. Seelenberger , See Remarks Tom C Thomas , and director & 10 percent owner & President and CEO Ahmed Md Hamdy .

Vincerx Pharma Inc (VINC) Insider Trades Summary

Over the past 18 months, David Dobkin made no insider transaction in Vincerx Pharma Inc (VINC). Other recent insider transactions involving Vincerx Pharma Inc (VINC) include a net purchase of 57,580 shares made by Ahmed Md Hamdy , a net purchase of 45,214 shares made by Raquel E. Izumi , and a net purchase of 12,000 shares made by Tom C Thomas .

In summary, during the past 3 months, insiders sold 0 shares of Vincerx Pharma Inc (VINC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Vincerx Pharma Inc (VINC) were sold and 125,294 shares were bought by its insiders, resulting in a net purchase of 125,294 shares.

Vincerx Pharma Inc (VINC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Vincerx Pharma Inc Insider Transactions

No Available Data

David Dobkin Mailing Address

Above is the net worth, insider trading, and ownership report for David Dobkin. You might contact David Dobkin via mailing address: 250 W. 55th St., #3401, New York Ny 10019.

Discussions on David Dobkin

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.